Rubiato, Gyne Kurl .

HRN: 21-07-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
CEFUROXIME 1.5GM (VIAL)
04/18/2026
04/19/2026
IV
1.5 Grams
Q8 X 3 Doses
SP NSD W RMLE, RBOW
Remove - Pending Acceptance
04/18/2026
CEFUROXIME 500MG (TAB)
04/19/2026
04/26/2026
PO
1 Tab
BID
SP NSD W RMLE; RBOW
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: